Found 6 results

Name Type of Offering Accepted Date
ANTERIOS INC
D 2010-09-03
Amount To Be Raised $2,500,000
Associated Brokers / Dealers N/A
CIK Number 0001390085
Filed Document 0001390085-10-000002
Exclusions or Exemptions N/A
Accepted Date 2010-09-03
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets No Revenues
Type of Security Equity
ANTERIOS INC
D 2011-07-22
Amount To Be Raised $3,500,001
Associated Brokers / Dealers N/A
CIK Number 0001390085
Filed Document 0001390085-11-000001
Exclusions or Exemptions N/A
Accepted Date 2011-07-22
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Equity
ANTERIOS INC
D 2009-10-21
Amount To Be Raised $10,000,000
Associated Brokers / Dealers N/A
CIK Number 0001390085
Filed Document 0001390085-09-000004
Exclusions or Exemptions N/A
Accepted Date 2009-10-21
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets No Revenues
Type of Security Equity
ANTERIOS INC
D 2010-12-29
Amount To Be Raised $1,999,992
Associated Brokers / Dealers N/A
CIK Number 0001390085
Filed Document 0001390085-10-000004
Exclusions or Exemptions 505
Accepted Date 2010-12-29
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets No Revenues
Type of Security Equity
ANTERIOS INC
D 2010-02-18
Amount To Be Raised $1,500,000
Associated Brokers / Dealers N/A
CIK Number 0001390085
Filed Document 0001390085-10-000001
Exclusions or Exemptions 505
Accepted Date 2010-02-18
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets No Revenues
Type of Security Equity
ANTERIOS INC
D 2013-04-09
Amount To Be Raised $6,612,829
Associated Brokers / Dealers N/A
CIK Number 0001390085
Filed Document 0001390085-13-000001
Exclusions or Exemptions N/A
Accepted Date 2013-04-09
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Equity